Drug alerts › Taj Pharma India Ltd.
Taj Pharma India Ltd.: drug alert entries
Batches made by Taj Pharma India Ltd. (as named by CDSCO) that appear in CDSCO drug alerts: 4 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Orlistat Capsules USP 120 mgNSQ
Result: 01.IDENTIFICATION TEST OF ORLISTAT U.S.P. – Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.
Obelow-60 (Orlistat Capsules USP 60 mg (Obelow-120)NSQ
Result: 01. IDENTIFICATION TEST OF ORLISTAT U.S.P. – Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.
Metformin HCl I.P. (as Prolonged Release Form & Glimepiride I.P (Glyglim-M2)NSQ
Result: Assay of Glimepiride IP- less than Prescribed limit
Voglibose, Glimepiride & Metformin HCl (SR) Tablets). (Glyglim-MV1)NSQ
Result: Description : one out of 20 tablets blue layer half broken found. & Assay of Glimepiride IP- less than Prescribed limit